
DRI Healthcare Trust (TSE:DHT.UN) reported higher first-quarter income and expanded margins as management said the royalty investment company continued to benefit from its post-internalization cost structure and growth across several portfolio assets.
Chief Executive Officer Ali Hedayat said the company generated total income of $50.6 million in the first quarter of 2026, up 15% year over year and a first-quarter record for DRI. Royalty income rose 18%, supported by double-digit growth from assets including EMPAVELI, ORSERDU, XENPOZYME and XOLAIR. That strength was partially offset by softer performance from VONJO, RYDAPT and ORACEA.